Fibroblast growth factor 19 is correlated with an unfavorable prognosis and promotes progression by activating fibroblast growth factor receptor 4 in advanced-stage serous ovarian cancer

Lingling Hu(Linyi People's Hospital), LAN-XIANG CONG(Linyi People's Hospital)
Oncology Reports
August 20, 2015
Cited by 31


Related Papers